{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/04/24/3280641/0/en/Press-Release-Sanofi-s-Cenrifki-tolebrutinib-recommended-for-EU-approval-by-the-CHMP-to-treat-secondary-progressive-multiple-sclerosis-without-relapses.html", "message": "News view counter 680006 successfully enlarged"}